Moderna produces one of three COVID shots available in the U.S.1 In November 2021, Moderna released data on third-quarter sales showing phenomenal profits from the vaccine of $ 5 billion worldwide and forecasted $ 18 billion for the year just from the mRNA vaccine.2 To take advantage of this revenue stream, the company announced they… Read More »
[unable to retrieve full-text content]TUESDAY, Oct. 5, 2021 — Medtronic has expanded a recall of its MiniMed 600 series insulin pumps to include more than 463,000 of the devices. The pumps may deliver incorrect dosing of insulin and the recall has been identified by the U.S. Food and… Drugs.com – Daily MedNews
[unable to retrieve full-text content]SUNDAY, Oct. 3, 2021 — Although the focus is on the COVID-19 vaccine, don’t forget to also get your flu shot — it’s important, an expert says. “In the United States, it is recommended that everyone over the age of 6 months be vaccinated against… Drugs.com – Daily MedNews
PORTLAND, Maine — Maine’s rural areas need better access to COVID-19 testing, the head of the state’s Center for Disease Control and Prevention said. The percent positivity rate in some of Maine’s rural counties is much higher than it is in more densely populated areas such as Cumberland County. Federal data show the percent positivity… Read More »
[unable to retrieve full-text content]Boris Johnson says the donations to countries in need will begin within weeks. BBC News – Health
The medical group for Walmart Health has filed paperwork to do business in more than a dozen more states – and a spokesperson told Insider that the moves are not related to physical clinics. Instead, the preparation regards the retail giant’s pending acquisition of telehealth vendor MeMD earlier this year. “We’ve expressed our… Read More »
Karen Gorby By Karen S. Gorby, RN, MSN, MBA, CENP, FACHE It’s May, and as we enjoy a beautiful spring — as well as the chance to get out and about more since we have been fortunate to have access to the COVID-19 vaccine — it promises to be quite different than last year’s. Twelve… Read More »
When Ipsen announced last week that it wanted in on Exelixis’ Cabometyx for thyroid cancer, the company pegged that move to the oncology drug’s promising late-stage trial results. Now, Exelixis is offering up more details of that very trial. For a phase 3 study up for presentation at the virtual American Society of Clinical Oncology meeting, investigators… Read More »